LTR advanced another +2% on Wednesday as the financials look increasingly attractive moving into 2025: LTR ended the December half with $192 million in cash, and Spodumene AISC of US$763/t, providing excellent leverage to an increase in the Li price, i.e. if the market decides Li could head toward $US900/t, in 2025 the stock is likely to pop aggressively.
- No change, we can see LTR testing 90c in the coming months, or 30% higher—MM holds LTR in our Emerging Companies Portfolio.